North America Pharmaceutical Supply Chain Management Market Forecast 2023-2032

The North America pharmaceutical supply chain management market is estimated to register a CAGR of 8.93% during the forecasting years of 2023-2032. Some of the leading factors augmenting the region's market growth include the continuous innovation in vaccination as well as drug development, the high adoption rate of modern, cutting-edge technologies, and the presence of leading pharmaceutical companies.

MARKET INSIGHTS

Canada and the United States are evaluated for the North America pharmaceutical supply chain management market growth analysis. According to industry sources, hospitals in Canada purchase around $4 billion per annum of medical products, including diagnostics, drugs, and devices. However, aspects such as the growing use of modern technology, the customization of healthcare, the demographics of an aging population, and the country's spread-out population place the Canadian healthcare supply chain under tremendous pressure. These factors, in turn, play a vital role in increasing the demand for pharmaceutical supply chain management in the country.

On the other hand, the healthcare business in Canada is rapidly expanding, primarily on account of the increased investment from both the public as well as private sectors. Furthermore, the COVID-19 pandemic revealed massive vulnerabilities, especially demonstrated by the shortage in Canada's PPE supply, which presented a major challenge during the initial months of the outbreak. In this regard, the implementation of GS1 in the country can enable Canadian healthcare providers to streamline their supply chain processes. As a result, these factors are set to propel the North America pharmaceutical supply chain management market growth during the forecast period.

COMPETITIVE INSIGHTS

Key players operating in the market are: Infor, McKesson Corporation, Oracle Corporation, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 51600

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASING APPLICATION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
- 3.1.2. ADOPTION OF GS1 STANDARD SYSTEM
- 3.1.3. GROWING PRESSURE TO REDUCE HEALTHCARE COSTS
- 3.1.4. SURGING DEMAND FOR PHARMACEUTICALS PRODUCTS
- 3.1.5. HIGH PREVALENCE OF DRUG COUNTERFEITING IN THE PHARMA INDUSTRY
3.2. KEY RESTRAINTS
- 3.2.1. STRINGENT REGULATIONS IN HEALTHCARE DATA EXCHANGE
- 3.2.2. HIGH OPERATIONAL COSTS OF HEALTHCARE SCM SOFTWARE
- 3.2.3. TECHNICAL PROBLEMS ASSOCIATED WITH SCM SOFTWARE
- 3.2.4. SECURITY ISSUES IN WEAK SCM LINKS

4. KEY ANALYTICS

4.1. KEY TECHNOLOGY TRENDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. MARKET CONCENTRATION ANALYSIS
4.5. MARKET MATURITY ANALYSIS

5. MARKET BY COMPONENT

5.1. SOLUTION
- 5.1.1. TRANSPORTATION MANAGEMENT SYSTEM
- 5.1.2. PLANNING & ANALYTICS
- 5.1.3. WAREHOUSE & INVENTORY MANAGEMENT SYSTEM
- 5.1.4. PROCUREMENT & SOURCING
- 5.1.5. MANUFACTURING EXECUTION SYSTEM
5.2. SERVICE
- 5.2.1. PROFESSIONAL SERVICES
- 5.2.2. MANAGED SERVICES

6. MARKET BY DEPLOYMENT MODE

6.1. ON-PREMISE
6.2. CLOUD-BASED

7. GEOGRAPHICAL ANALYSIS

7.1. NORTH AMERICA
- 7.1.1. MARKET SIZE & ESTIMATES
- 7.1.2. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
- 7.1.3. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
- 7.1.4. NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
- 7.1.5. KEY PLAYERS IN NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
- 7.1.6. COUNTRY ANALYSIS
  - 7.1.6.1. UNITED STATES
  - 7.1.6.1.1. UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.2. CANADA
  - 7.1.6.2.1. CANADA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. PRODUCT LAUNCHES
- 8.1.2. PARTNERSHIPS
8.2. COMPANY PROFILES
- 8.2.1. ARVATO SUPPLY CHAIN SOLUTIONS
  - 8.2.1.1. COMPANY OVERVIEW
  - 8.2.1.2. PRODUCTS / SERVICES LIST
- 8.2.2. CARDINAL HEALTH
  - 8.2.2.1. COMPANY OVERVIEW
  - 8.2.2.2. PRODUCTS / SERVICES LIST
  - 8.2.2.3. STRENGTHS & CHALLENGES
- 8.2.3. EPICOR SOFTWARE CORPORATION
  - 8.2.3.1. COMPANY OVERVIEW
  - 8.2.3.2. PRODUCTS / SERVICES LIST
- 8.2.4. GLOBAL HEALTHCARE EXCHANGE LLC
  - 8.2.4.1. COMPANY OVERVIEW
  - 8.2.4.2. PRODUCTS / SERVICES LIST
  - 8.2.4.3. STRENGTHS & CHALLENGES
- 8.2.5. INFOR
  - 8.2.5.1. COMPANY OVERVIEW
  - 8.2.5.2. PRODUCTS / SERVICES LIST
  - 8.2.5.3. STRENGTHS & CHALLENGES
- 8.2.6. JUMP TECHNOLOGIES
  - 8.2.6.1. COMPANY OVERVIEW
  - 8.2.6.2. PRODUCTS / SERVICES LIST
- 8.2.7. LOGITAG SYSTEMS
  - 8.2.7.1. COMPANY OVERVIEW
  - 8.2.7.2. PRODUCTS / SERVICES LIST
- 8.2.8. MANHATTAN ASSOCIATES
  - 8.2.8.1. COMPANY OVERVIEW
  - 8.2.8.2. PRODUCTS / SERVICES LIST
  - 8.2.8.3. STRENGTHS & CHALLENGES
- 8.2.9. MCKESSON CORPORATION
  - 8.2.9.1. COMPANY OVERVIEW
  - 8.2.9.2. PRODUCTS / SERVICES LIST
  - 8.2.9.3. STRENGTHS & CHALLENGES
- 8.2.10. ORACLE CORPORATION
  - 8.2.10.1. COMPANY OVERVIEW
  - 8.2.10.2. PRODUCTS / SERVICES LIST
  - 8.2.10.3. STRENGTHS & CHALLENGES
- 8.2.11. SAP SE
  - 8.2.11.1. COMPANY OVERVIEW
  - 8.2.11.2. PRODUCTS / SERVICES LIST
  - 8.2.11.3. STRENGTHS & CHALLENGES
- 8.2.12. SPECTRUM HEALTH
  - 8.2.12.1. COMPANY OVERVIEW
  - 8.2.12.2. PRODUCTS / SERVICES LIST
- 8.2.13. TECSYS INC
  - 8.2.13.1. COMPANY OVERVIEW
  - 8.2.13.2. PRODUCTS / SERVICES LIST
  - 8.2.13.3. STRENGTHS & CHALLENGES
- 8.2.14. TERSO SOLUTION
  - 8.2.14.1. COMPANY OVERVIEW
  - 8.2.14.2. PRODUCTS / SERVICES LIST
  - 8.2.14.3. STRENGTHS & CHALLENGES
- 8.2.15. VIZIENT INC
  - 8.2.15.1. COMPANY OVERVIEW
  - 8.2.15.2. PRODUCTS / SERVICES LIST

Product Code: 51600

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT
TABLE 2: PRIMARY FACTORS CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
TABLE 3: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 5: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 7: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 9: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 11: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 13: KEY PLAYERS OPERATING IN THE NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
TABLE 14: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
TABLE 15: LIST OF PRODUCT LAUNCHES
TABLE 16: LIST OF PARTNERSHIPS

LIST OF FIGURES

FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR NORTH AMERICA
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2022
FIGURE 7: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2032 (IN $ MILLION)
FIGURE 8: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SOLUTION, IN 2022
FIGURE 9: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT SYSTEM, 2023-2032 (IN $ MILLION)
FIGURE 10: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING & ANALYTICS, 2023-2032 (IN $ MILLION)
FIGURE 11: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE & INVENTORY MANAGEMENT SYSTEM, 2023-2032 (IN $ MILLION)
FIGURE 12: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT & SOURCING, 2023-2032 (IN $ MILLION)
FIGURE 13: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION SYSTEM, 2023-2032 (IN $ MILLION)
FIGURE 14: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2032 (IN $ MILLION)
FIGURE 15: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2022
FIGURE 16: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES, 2023-2032 (IN $ MILLION)
FIGURE 17: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2032 (IN $ MILLION)
FIGURE 18: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODE, IN 2022
FIGURE 19: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2032 (IN $ MILLION)
FIGURE 21: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 22: UNITED STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: CANADA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)